<DOC>
	<DOCNO>NCT01346748</DOCNO>
	<brief_summary>Delayed ischemia cause cerebral vasospasm remain common cause morbidity mortality aneurysmal subarachnoid hemorrhage . A great deal drug test last year . Phase II randomize clinical trial demonstrate statin decrease incidence symptomatic cerebral vasospasm spontaneous subarachnoid hemorrhage . Clinical , double blind , randomize control trial placebo . Discussion : Even though article show statin provide good prognosis , issue remain debate , e.g. , treatment duration choice statin .</brief_summary>
	<brief_title>The Role Statins Preventing Cerebral Vasospasm Secondary Subarachnoid Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Age 18 65 year old , Hunthess scale &lt; 3 Liver disfunction , previous use statin , hunthess scale 4 5 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>vasospasm prevention</keyword>
</DOC>